FORA Capital’s Orthofix Medical OFIX Stock Holding History

FORA Capital’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,355	Closed	-$38K	–	1188
2020 Q1	$38K	Buy	+1,355	New	+$52.4K	0.01%	831

Other funds holding OFIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FORA Capital's OFIX Position: Q2 2020 in Review

FORA Capital sold out of Orthofix Medical (OFIX) in Q2 2020, closing a stake of 1,355 shares — an estimated $38K sold.

FORA Capital first reported a position in OFIX in Q1 2020 and held it in 1 quarter. The position peaked at $38K in Q1 2020. 140 funds tracked by Wall St. Rank hold OFIX as of Q2 2020.

FORA Capital reported no remaining Orthofix Medical position as of Q2 2020 after selling out during the quarter.
FORA Capital sold 1,355 Orthofix Medical shares in Q2 2020, an estimated $38K.
FORA Capital first reported a position in Orthofix Medical in Q1 2020 and held it in 1 quarter.
FORA Capital's Orthofix Medical position peaked at $38K in Q1 2020.
140 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2020.

Based on FORA Capital's 13F filing for Q2 2020, filed 14 Aug 2020.